
    
      Participants will be randomly assigned, in a 1:1 ratio, to receive Edaravone or control (0.9
      %Sodium Chloride Solution,0.9%NaCl). The randomization sequence will be computer-generated,
      and randomization will be performed in blocks and will be stratified according to
      participating center.Edaravone and 0.9 %NaCl solution will be treated at 10 minutes before
      kidney reperfusion, ending in 30 minutes. The number of dialysis and the serum creatinine
      level within the first week after the transplantation will be recorded. The participation of
      each patient is scheduled for 1 month.
    
  